Results for tag: "Erwinaze"

Erwinaze is a market of drugs used to treat acute lymphoblastic leukemia (ALL). It is a type of chemotherapy that works by targeting and destroying cancer cells. Erwinaze is a combination of two drugs, asparaginase and methotrexate, which are used to treat ALL. Asparaginase works by breaking down the amino acid asparagine, which is essential for cancer cell growth. Methotrexate works by blocking the production of folic acid, which is also necessary for cancer cell growth. Erwinaze is used in combination with other chemotherapy drugs to treat ALL. The Erwinaze market is highly competitive, with many companies offering their own versions of the drug. Some of the companies in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and Amgen. Show Less Read more